	رأس المال والاحتياطيات		تاريخ
Abbott	USD 52.13B	1.3B	2025-12
Acadia Pharmaceuticals	USD 917.27M	94.89M	2025-09
Agios Pharmaceuticals	USD 1.19B	91.22M	2025-12
Akebia Therapeutics	USD 32.61M	8.98M	2025-12
Alnylam Pharmaceuticals	USD 789.18M	555.28M	2025-12
AstraZeneca	USD 48.67B	2.78B	2025-12
BioMarin Pharmaceutical	USD 6.09B	30.29M	2025-12
Coherus Biosciences	USD 87.77M	32.05M	2025-09
Eli Lilly	USD 26.54B	2.74B	2025-12
Esperion Therapeutics	USD -451.36M	17.85M	2025-09
Halozyme Therapeutics	USD 48.81M	455.1M	2025-12
Illumina	USD 2.72B	342M	2025-12
Insmed	USD 738.98M	206.6M	2025-12
Ironwood Pharmaceuticals	USD -264.16M	44M	2025-09
J&J	USD 78.47B	0	2025-09
Lexicon Pharmaceuticals	USD 129.44M	6.41M	2025-06
MacroGenics	USD 67M	20.38M	2025-09
MannKind	USD -51.02M	6.47M	2025-12
Merck	USD 51.85B	2.79B	2025-09
Moderna	USD 8.65B	680M	2025-12
Novartis	USD 44.75B	2.7B	2025-09
PTC Therapeutics	USD -205.31M	49.56M	2025-12
Puma Biotechnology	USD 115.27M	10.55M	2025-09
Sarepta Therapeutics	USD 1.14B	179.5M	2025-12
Thermo Fisher Scientific	USD 53.54B	2.38B	2025-12
Ultragenyx Pharmaceutical	USD 9.16M	142.13M	2025-09
United Therapeutics	USD 7.1B	506M	2025-12
Vanda Pharmaceuticals	USD 327.19M	138.81M	2025-12

Lexicon Pharmaceuticals رأس المال والاحتياطيات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2026.